| Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched … F Baron, C Lechanteur, E Willems, F Bruck, E Baudoux, L Seidel, ... Biology of blood and marrow transplantation 16 (6), 838-847, 2010 | 288 | 2010 |
| Clinical-scale expansion of mesenchymal stromal cells: a large banking experience C Lechanteur, A Briquet, O Giet, O Delloye, E Baudoux, Y Beguin J Transl Med 14, 145, 2016 | 163 | 2016 |
| Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I–II, open-label, clinical study O Detry, M Vandermeulen, MH Delbouille, J Somja, N Bletard, A Briquet, ... Journal of hepatology 67 (1), 47-55, 2017 | 130 | 2017 |
| Family-directed umbilical cord blood banking E Gluckman, A Ruggeri, V Rocha, E Baudoux, M Boo, J Kurtzberg, ... Haematologica 96 (11), 1700, 2011 | 105 | 2011 |
| Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study P Erpicum, L Weekers, O Detry, C Bonvoisin, MH Delbouille, C Grégoire, ... Kidney international 95 (3), 693-707, 2019 | 101 | 2019 |
| Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy V Rocha, S Spellman, MJ Zhang, A Ruggeri, D Purtill, C Brady, ... Biology of Blood and Marrow Transplantation 18 (12), 1890-1896, 2012 | 97 | 2012 |
| Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial JP Hauzeur, V De Maertelaer, E Baudoux, M Malaise, Y Beguin, V Gangji International Orthopaedics 42, 1429-1435, 2018 | 96 | 2018 |
| Mesenchymal Stromal Cell Therapy for Inflammatory Bowel Diseases C Grégoire, C Lechanteur, A Briquet, É Baudoux, F Baron, E Louis, ... Alimentary pharmacology & therapeutics 45 (2), 205-221, 2017 | 94 | 2017 |
| Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease M Hannon, C Lechanteur, S Lucas, J Somja, L Seidel, L Belle, F Bruck, ... Transfusion 54 (2), 353-363, 2014 | 81 | 2014 |
| Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. F Baron, J Siquet, N Schaaf-Lafontaine, E Baudoux, JP Hermanne, ... haematologica 87 (1), 2002 | 80 | 2002 |
| Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation JP Salmon, S Michaux, JP Hermanne, E Baudoux, C Gerard, ... Transfusion 39 (8), 824-827, 1999 | 75 | 1999 |
| Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence M Jacquet, V Lambert, E Baudoux, M Muller, P Kremers, J Gielen European Journal of Cancer 32 (10), 1701-1706, 1996 | 65 | 1996 |
| Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by … M André, E Baudoux, D Bron, JL Canon, V D'Hondt, MF Fassotte, ... Transfusion 43 (1), 50-57, 2003 | 64 | 2003 |
| Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen A Ruggeri, M Labopin, MP Sormani, G Sanz, J Sanz, F Volt, G Michel, ... haematologica 99 (9), 1509, 2014 | 63 | 2014 |
| Large-scale clinical expansion of mesenchymal stem cells in the GMP-compliant, closed automated quantum® cell expansion system: comparison with expansion in traditional T-flasks C LECHANTEUR, S Baila, ME Janssen, O GIET, A BRIQUET, ... Journal of Stem Cell Research and Therapy 4 (8), 2014 | 57 | 2014 |
| MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process C Lechanteur, A Briquet, V Bettonville, Baudoux, Etienne, Y Beguin Cells 10 (6), 2021 | 46 | 2021 |
| Cord blood banking A Brand, P Rebulla, CP Engelfriet, HW Reesink, Y Beguin, E Baudoux, ... Vox Sanguinis: 95 (4), 335, 2008 | 46 | 2008 |
| Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation F Baron, B Sautois, E Baudoux, G Matus, G Fillet, Y Beguin Experimental hematology 30 (6), 546-554, 2002 | 41 | 2002 |
| Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells Y Beguin, E Baudoux, B Sautois, V Fraipont, N Schaaf‐Lafontaine, ... Transfusion 38 (2), 199-208, 1998 | 40 | 1998 |
| Access to human tissues for research and product development JP Pirnay, E Baudoux, O Cornu, A Delforge, C Delloye, J Guns, E Heinen, ... EMBO Reports, 2015 | 38* | 2015 |
Yves BeguinUniversité de LiègeAdresse e-mail validée de uliege.be
